The stock also got a boost from the company’s announcement in the post-earnings call stating that Dr Reddy’s plans to spend up to $300 million on research and development (R&D) during the current financial year. Dr Reddy’s Shares Recover 4% on Hopes of Higher R&D Spend
The stock also got a boost from the company’s announcement in the post-earnings call stating that Dr Reddy’s plans to spend up to $300 million on research and development (R&D) during the current financial year. Dr Reddy’s Shares Recover 4% on Hopes of Higher R&D Spend
No comments:
Post a Comment